Approval · Notice of Compliance 1464 · 2000
SEVORANE AF: Notice of Compliance 1464
Issued December 8, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1464
- Date
- December 8, 2000
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- Product name change from sevorane
- Therapeutic class
- Inhalation anaesthetic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SEVORANE AF | 02172763 | Marketed |
Medicinal ingredients
- SEVOFLURANE 99.975 PER